Pro Share Advisors LLC Harrow Health, Inc. Transaction History
Pro Share Advisors LLC
- $42.5 Billion
- Q4 2024
A detailed history of Pro Share Advisors LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 10,289 shares of HROW stock, worth $246,833. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,289
Previous 7,868
30.77%
Holding current value
$246,833
Previous $353,000
2.27%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HROW
# of Institutions
188Shares Held
21MCall Options Held
679KPut Options Held
1.27M-
Opaleye Management Inc. Boston, MA3.99MShares$95.7 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$51.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$44.9 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$40.7 Million6.85% of portfolio
-
Braidwell LP Stamford, CT907KShares$21.8 Million1.7% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $649M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...